Noida, UP -- (SBWire) -- 12/16/2014 --The miRNA market in Europe was estimated to be around US$ 56 Million in 2013, and is likely to reach US$ 123 Million by 2018. The growth can be attributed to the active research environment of the country, generous funding and support provided by the regulatory authorities, and high standards of research infrastructure and intellect.
The report "Global miRNA Market Outlook to 2018", covers present and future outlook for the two broad categories of miRNA; the tools and services segments. The former comprises of the various tools that are used to study miRNA. These include isolation kits, PCR arrays, labels, markers, mimics and inhibitors. On the other hand, the latter includes the various services such as purification, expression profiling, quantitation and analysis that are offered by miRNA players. The market has been divided into three sections i.e., The Americas, Europe and Asia Pacific. These regions have then been analyzed to draw patterns in terms of research areas and applicability. A brief look at the market suggests that cancer is the most researched topic and regions such as United States, United Kingdom, France, Israel and China are the major players interested in evaluating the role played by miRNA.
Most of the current research is focused on utilizing miRNA for diagnostic purposes such as expression profiling, response evaluation and setting potential biomarkers in diseases. Another application is in the field of therapeutics where miRNA mimics and inhibitors are being applied to control gene translation and consequently its expression.
After an exhaustive study of the industry, RNCOS has laid out the primary market players which engaged in providing miRNA based tools and services. These players are working over a vast variety of products such as miRNA extraction and purification kits, and miRNA mimics and inhibitors. Some of them include Qiagen, Life Technologies, Exiqon and Mirus Bio.
For FREE SAMPLE of this report visit:
http://www.rncos.com/Report/IM649.htm
Check Related REPORTS on:
http://www.rncos.com/Healthcare_Industry.htm
About RNCOS
RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.
miRNA Market in Europe to Reach US$ 123 Million by 2018
“Europe is the second largest market for miRNA research, with the France as the country wherein majority of the research associated with miRNA diagnostics/therapeutics application is being carried on”, says RNCOS.